Results of COVID-minimal Surgical Pathway During Surge-phase of COVID-19 Pandemic
Authors:
- 19 October 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 272 (6) , e316-e320
Abstract
Objective: The outcomes of patients treated on the COVID-minimal pathway were evaluated during a period of surging COVID-19 hospital admissions, to determine the safety of continuing to perform urgent operations during the pandemic. Summary of Background Data: Crucial treatments were delayed for many patients during the COVID-19 pandemic, over concerns for hospital-acquired COVID-19 infections. To protect cancer patients whose survival depended on timely surgery, a “COVID-minimal pathway” was created. Methods: Patients who underwent a surgical procedure on the pathway between April and May 2020 were evaluated. The “COVID-minimal surgical pathway” consisted of: (A) evolving best-practices in COVID-19 transmission-reduction, (B) screening patients and staff, (C) preoperative COVID-19 patient testing, (D) isolating pathway patients from COVID-19 patients. Patient status through 2 weeks from discharge was determined as a reflection of hospital-acquired COVID-19 infections. Results: After implementation, pathway screening processes excluded 7 COVID-19-positive people from interacting with pathway (4 staff and 3 patients). Overall, 122 patients underwent 125 procedures on pathway, yielding 83 admissions (42 outpatient procedures). The median age was 64 (56–79) and 57% of patients were female. The most common surgical indications were cancer affecting the uterus, genitourinary tract, colon, lung or head and neck. The median length of admission was 3 days (1–6). Repeat COVID-19 testing performed on 27 patients (all negative), including 9 patients evaluated in an emergency room and 8 readmitted patients. In the postoperative period, no patient developed a COVID-19 infection. Conclusions: A COVID-minimal pathway comprised of physical space modifications and operational changes may allow urgent cancer treatment to safely continue during the COVID-19 pandemic, even during the surge-phase.Keywords
This publication has 19 references indexed in Scilit:
- Pandemic Recovery Using a COVID-Minimal Cancer Surgery PathwayThe Annals of Thoracic Surgery, 2020
- COVID-19 Guidance for Triage of Operations for Thoracic Malignancies: A Consensus Statement From Thoracic Surgery Outcomes Research NetworkThe Annals of Thoracic Surgery, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infectioneClinicalMedicine, 2020
- Clinical and Transmission Characteristics of Covid-19 — A Retrospective Study of 25 Cases from a Single Thoracic Surgery DepartmentCurrent Medical Science, 2020
- COVID-19 Outbreak and Surgical PracticeAnnals of Surgery, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020
- Impact of delay to surgery on survival in stage I-III colon cancerEuropean Journal of Surgical Oncology, 2020
- Defining the Ideal Time Interval Between Planned Induction Therapy and Surgery for Stage IIIA Non-Small Cell Lung CancerThe Annals of Thoracic Surgery, 2017
- Delay in Diagnostic Workup and Treatment of Esophageal CancerJournal of Gastrointestinal Surgery, 2009